Karuna Therapeutics Stock Number Of Employees
Karuna Therapeutics fundamentals help investors to digest information that contributes to Karuna Therapeutics' financial success or failures. It also enables traders to predict the movement of Karuna Stock. The fundamental analysis module provides a way to measure Karuna Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Karuna Therapeutics stock.
Karuna |
Karuna Therapeutics Company Number Of Employees Analysis
Karuna Therapeutics' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Karuna Therapeutics Number Of Employees | 339 |
Most of Karuna Therapeutics' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Karuna Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Karuna Therapeutics is currently employing 339 people. This is 96.92% lower than that of the Biotechnology sector and 36.68% lower than that of the Health Care industry. The number of employees for all United States stocks is 98.2% higher than that of the company.
Karuna Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Karuna Therapeutics' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Karuna Therapeutics could also be used in its relative valuation, which is a method of valuing Karuna Therapeutics by comparing valuation metrics of similar companies.Karuna Therapeutics is currently under evaluation in number of employees category among its peers.
Karuna Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.25 | |||
| Operating Margin | (755.64) % | |||
| Current Valuation | 11.35 B | |||
| Shares Outstanding | 38.2 M | |||
| Shares Owned By Insiders | 4.98 % | |||
| Shares Owned By Institutions | 86.32 % | |||
| Number Of Shares Shorted | 1.97 M | |||
| Price To Earning | (19.88) X | |||
| Price To Book | 10.05 X | |||
| Price To Sales | 19,265 X | |||
| Revenue | 654 K | |||
| Gross Profit | 10.64 M | |||
| EBITDA | (493.08 M) | |||
| Net Income | (433.68 M) | |||
| Cash And Equivalents | 407.41 M | |||
| Cash Per Share | 13.60 X | |||
| Total Debt | 16.69 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 17.77 X | |||
| Book Value Per Share | 32.94 X | |||
| Cash Flow From Operations | (385.82 M) | |||
| Short Ratio | 3.60 X | |||
| Earnings Per Share | (11.74) X | |||
| Price To Earnings To Growth | 1.46 X | |||
| Target Price | 324.17 | |||
| Number Of Employees | 339 | |||
| Beta | 1.15 | |||
| Market Capitalization | 12.6 B | |||
| Total Asset | 1.34 B | |||
| Retained Earnings | (997.89 M) | |||
| Working Capital | 1.25 B | |||
| Current Asset | 6.24 M | |||
| Current Liabilities | 8.73 M | |||
| Net Asset | 1.34 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Karuna Stock
If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |